(Q41101493)

26 September 2017

title

Randomized, double-blind study of cefotetan and cefoxitin in post-cesarean section endometritis (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1442917

27 September 2022

0 references

R. R. MacGregor

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1442917

27 September 2022

A. L. Graziani

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1442917

27 September 2022

P. Samuels

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1442917

27 September 2022

language of work or name

English

0 references

publication date

1 July 1992

1 reference

American Journal of Obstetrics and Gynecology

26 September 2017

published in

1 reference

26 September 2017

volume

167

1 reference

26 September 2017

issue

1

1 reference

26 September 2017

page(s)

139-143

1 reference

Cefotetan. A review of its antibacterial activity, pharmacokinetic properties and therapeutic use.

26 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2811%2991648-2

The effects of cefotetan disodium on haemostasis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2811%2991648-2

Multicenter comparison of cefotetan and cefoxitin in the treatment of acute obstetric and gynecologic infections

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2811%2991648-2

Results of noncomparative studies of cefotetan in the treatment of obstetric and gynecologic infections.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2811%2991648-2

Cefotetan in the treatment of obstetric and gynecologic infections

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2811%2991648-2

Multicenter clinical trials comparing cefotetan with moxalactam or cefoxitin as therapy for obstetric and gynecologic infections

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2811%2991648-2

Perspectives on the bacteriology of postoperative obstetric-gynecologic infections

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2811%2991648-2

A double-blind, randomized comparison of moxalactam versus clindamycin-gentamicin in treatment of endomyometritis after cesarean section delivery

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2811%2991648-2

Antimicrobial therapy of postpartum endomyometritis. II. Prospective, randomized trial of mezlocillin versus ampicillin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2811%2991648-2

Ampicillin/sulbactam versus metronidazole-gentamicin in the treatment of soft tissue pelvic infections

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2811%2991648-2

Cefotetan and hypoprothrombinemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2811%2991648-2

Pathophysiology and management of postcesarean endomyometritis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2811%2991648-2

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/S0002-9378(11)91648-2

1 reference

26 September 2017

1 reference